Evidence map›Paper›PMID 40888978›Full record

ArticleAnalytical and bioanalytical chemistry2026

Global metabolomics profiling of glucuronides in human plasma, fecal, and cerebrospinal fluid samples.

Ioanna Tsiara, Mario S P Correia, Fan Yang, Weiming Zeng, Pauline Seeburger, Belén Hervás Povo, Iben Lundgaard, Manuel Menéndez-González, Miroslav Vujasinovic, J-Matthias Löhr and 1 more

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ioanna TsiaraDepartment of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Box 576, 75124, Uppsala, Sweden.
Mario S P CorreiaDepartment of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Box 576, 75124, Uppsala, Sweden.
Fan YangDepartment of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Box 576, 75124, Uppsala, Sweden.
Weiming ZengDepartment of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Box 576, 75124, Uppsala, Sweden.
Pauline SeeburgerDepartment of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Box 576, 75124, Uppsala, Sweden.
Belén Hervás PovoDepartment of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Box 576, 75124, Uppsala, Sweden.
Iben LundgaardDepartment of Experimental Medical Science, Lund University, 22362, Lund, Sweden.
Manuel Menéndez-GonzálezDepartment of Medicine, Universidad de Oviedo, 33006, Oviedo, Asturias, Spain.
Miroslav VujasinovicDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.
J-Matthias LöhrDepartment for Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
Daniel GlobischDepartment of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Box 576, 75124, Uppsala, Sweden. Daniel.globisch@kemi.uu.se.ORCID http://orcid.org/0000-0002-4526-5788

Funding

Cancerfonden 22 2449 PjH2020 European Research Council 101096309Vetenskapsrådet 2020-04707
6 · The paper itself

Abstract

Glucuronidation is the major phase II biotransformation reaction that facilitates the clearance of exogenous compounds from the human body. Glucuronidated metabolites have been investigated in urine samples at a broad scale; however, their characterization in other human biospecimens is underexplored. Our study has now performed a comprehensive profiling of glucuronides in plasma, fecal, and cerebrospinal fluid (CSF) of humans. We performed a mass spectrometry-based analysis that combines enzymatic hydrolysis with a β-glucuronidase to selectively cleave the glucuronic acid moiety, a developed in-house glucuronide identification pipeline, and enzymatic synthesis of standard metabolites. In total, we identified 32 glucuronidated metabolites across the three sample types in both negative and positive mass spectrometry ionization modes using advanced MS/MS fragmentation analysis. We have utilized a straightforward enzymatic synthesis of glucuronidated metabolites for annotation at the highest confidence level. Among the identified conjugates, we detected glucuronides of different compound classes including drugs, bile acid derivatives, steroid conjugates, and phenolic compounds. Unexpectedly, we validated the glucuronides of acetaminophen and propofol in CSF samples, the latter representing a novel observation that highlights the importance of investigating phase II metabolites in uncommon sample types.

Indexed as

FecesGlucuronidesMetabolomicsAcetaminophenGlucuronidaseHumansPropofolTandem Mass SpectrometryAcetaminophenGlucuronidaseGlucuronidesPropofolEnzymatic synthesisGlucuronidesGut microbiotaMetabolomicsPhase II modifications

Identifiers

PMID40888978
PMCPMC13423926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.